CRISPR Market by Product, Service, End User, Worth $550.0 Mn by 2030: Top Key Players - CRISPR THERAPEUTICS, Mirus Bio LLC, Takara Bio USA, Editas Medicine
The CRISPR technology is focused on development or growth of the gene therapeutics for the treatment of several genetic disorders including hemophilia, thalassemia, and sickle cell anemia, among others. The growing prevalence of hereditary disorders is promoting the growth of the market, for improved treatment and better quality of life for patients.
View full press release